Melisa Cooper
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
Papers in
- Pharmacology 12
- Antibiotics Pharmacokinetics and Efficacy 11
- Drug-Induced Adverse Reactions 2
-
- Antibiotic Resistance in Bacteria 7
- Co-authors
- Robert A. Wise (5 shared papers)J. M. Andrews (4 shared papers)J. M. Andrews (8 shared papers)M Logan (2 shared papers)R. Wise (5 shared papers)J. P. Ashby (3 shared papers)Raymond P. Bain (1 shared paper)N. Stanley Nahman (1 shared paper)
- Journals
- Journal of Antimicrobial Chemotherapy (9 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of the American Society of Nephrology (1 paper)Patient (1 paper)Kidney International (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Melisa Cooper
19 papers receiving 540 citations
Peers
Comparison fields: 5 of 81
- Molecular Medicine 159
- Nephrology 117
- Pharmacology 270
- Applied Microbiology and Biotechnology 24
- Clinical Biochemistry 38
Countries citing papers authored by Melisa Cooper
This map shows the geographic impact of Melisa Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melisa Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melisa Cooper more than expected).
Fields of papers citing papers by Melisa Cooper
This network shows the impact of papers produced by Melisa Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melisa Cooper. The network helps show where Melisa Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside Melisa Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 180 | |
| 2 | 1991 | 61 | |
| 3 | 1992 | 57 | |
| 4 | 1990 | 53 | |
| 5 | 1990 | 47 | |
| 6 | 1990 | 42 | |
| 7 | 2017 | 28 | |
| 8 | 2010 | 27 | |
| 9 | 1991 | 17 | |
| 10 | 1990 | 16 | |
| 11 | 1989 | 15 | |
| 12 | 1991 | 12 | |
| 13 | 1992 | 10 | |
| 14 | 2017 | 8 | |
| 15 | 1992 | 3 | |
| 16 | 2018 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 1992 | 1 | |
| 20 | 1991 | 1 |
About Melisa Cooper
Melisa Cooper is a scholar working on Pharmacology, Molecular Medicine, Epidemiology, Infectious Diseases and Molecular Biology, having authored 20 papers that have together received 583 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (7 papers), Pneumonia and Respiratory Infections (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Reproductive tract infections research (2 papers), Drug-Induced Adverse Reactions (2 papers), Pharmacological Effects and Toxicity Studies (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Molecular Medicine (159 citations), Nephrology (117 citations), Pharmacology (270 citations), Applied Microbiology and Biotechnology (24 citations) and Clinical Biochemistry (38 citations). Melisa Cooper has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Robert A. Wise, J. M. Andrews, J. M. Andrews, M Logan, R. Wise, J. P. Ashby, Raymond P. Bain, N. Stanley Nahman, Edmund J. Lewis and Janet B. McGill. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Journal of the American Society of Nephrology, Patient and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.